Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis

American Journal of Pathology

Volumn 149, Issue 4, 1996, Pages 1313-1320

  Exner, Markus ^a   Susani, Martin ^a   Witztum, Joseph L ^b   Hovorka, Anny ^a   Curtiss, Linda K ^c   Spitzauer, Susanne ^a   Kerjaschki, Dontscho ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; LIPOPROTEIN; MATRIX PROTEIN; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HEYMANN NEPHRITIS; IMMUNE COMPLEX DEPOSITION; IMMUNOCYTOCHEMISTRY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0029794357     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Llach F: Hypercoaguloability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985, 28:429-437
2. Schlöndorff D, Dendorfer U, Brumberger V, Keuneke C: Limitations of therapeutic approaches to glomerular diseases. Kidney Int 1995, 48:S19-S25
3. Heymann W, Knutec EP, Wilson SGF, Hunter JLP, Hackel DB, Okuda R, Cuppage L: Experimental autoimmune disease in rats. Ann NY Acad Sci 1965, 124:310-326
4. Edgington TS, Glassock RJ, Dixon JF: Autologous immune complex nephritis induced with renal tubular antigen: identification and isolation of the pathogenic antigen. J Exp Med 1968, 127:555-572
5. Miettinen A, Törnroth T, Tikkanen I, Virtanen I, Linder E: Heymann nephritis induced by kidney brush border glycoproteins. Lab Invest 1980, 43:547-555
6. Cavallo T: Membranous nephropathy: insights from Heymann nephritis. Am J Pathol 1994, 144:651-658
7. Farquhar MG, Kerjaschki D, Lundstrom M, Orlando-RA: Gp330 and RAP: the Heymann nephritis antigenic complex. Ann NY Acad Sci 1994, 737:96-113
8. Kerjaschki D: Molecular pathology of membranous nephropathy. Kidney Int 1992, 41:1090-1105
9. Shah SV: Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol 1988, 254:F337-F344
10. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, Kerjaschki D: Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 1993, 90:3645-3649
11. Esterbauer H, Jurgens G, Quehenberger O, Koller E: Autooxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 1987, 28:495-509
12. Neale TJ, Ojha P, Exner M, Poczewski H, Rueger B, Witztum JL, Davis P, Kerjaschki D: Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest 1994, 94:1577-1584
13. Witztum JL: The oxidation hypothesis of atherosclerosis. Lancet 1994, 344:793-795
14. Couser WG, Steinmüller DR, Stilmant MM, Salant DJ, Lowenstein LM: Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 1978, 62: 1275-1287
15. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL: Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990, 10:325-335
16. Itabe H, Takeshima E, Iwasaki H, Kimura J, Yoshida Y, Imanaku T, Takano T: A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions: complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem 1994, 269:15274-15279
17. Richmond W: Preparation and properties of a cholesterol oxidase from Nocardia species and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973, 19:1350-1356
18. Armbruster BL, Carlemalm E, Chiovetti R, Gravioti RM, Hobot JA, Kellenberger E, Vilinger W: Specimen preparation for electron microscopy using low temperature embedding resin. J Microsc 1982, 126:77-92
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275
20. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
21. Rodman JS, Kerjaschki D, Merisko E, Farquhar MG: Presence of an extensive clathrin coat on the apical plasmalemma of the rat kidney proximal tubule cell. J Cell Biol 1984, 98:1630-1636
22. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL: Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989, 86:1372-1376
23. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D: Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986, 77:641-644
24. Salonen JT, Ylä-Herttuala, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992, 339:883-887
25. Scanu AM: Physiopathology of plasma lipoprotein metabolism. Kidney Int 1991, 31:S3-S7
26. Oschry Y, Eisenberg S: Rat plasma lipoproteins: reevaluation of a lipoprotein system in an animal devoid of cholesteryl ester transfer activity. J Lipid Res 1982, 23:1099-1106
27. Basu SK, Goldstein JL, Brown MS: Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages. Science 1983, 219:871-873
28. Wallis SC, Rogne S, Gill L, Markham A, Edge M, Woods D, Williamson R, Humphries S: The isolation of cDNA clones for human apolipoprotein E and the detection of apoE RNA in hepatic and extra-hepatic tissues. EMBO J 1983, 2:2369-2373
29. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler S, Witztum JL: Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WWHL rabbits. Arteriosclerosis 1990, 10:336-349
30. Fong LG, Parthasarathy S, Witztum JL, Steinberg D: Nonenzymatic cleavage of peptide bonds in apoprotein B-100. J Lipid Res 1987, 28:1466-1477
31. McMillan JI, Riordan JW, Couser WG, Pollock AS, Lovett DH: Characterization of a glomerular epithelial cells metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 1996, 4:1094-1101
32. Gröne HJ, Walli AK, Gröne E, Krämer A, Clemens MR, Seidel D: Receptor mediated uptake of apoB and apoE enriched lipoproteins by human glomerular epithelial cells. Kidney Int 1990, 37:1449-1459
33. Saito A, Pietromonaco S, Loo AK, Farquhar MG: Complete cloning and sequencing of rat gp330/"megalin", a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci USA 1994, 91:9725-9729
34. Williams SE, Kounnas MZ, Argraves KM, Argraves WS, Strickland DK: The α2-macroglobulin receptor/low density lipoprotein receptor-related protein and the receptor-associated protein: an overview. Ann NY Acad Sci 1994, 737:1-13
35. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 1991, 39:S29-S35
36. Sato H, Suzuki S, Ueno M, Shimada H, Karasawa R, Hishi SI, Arakawa M: Localization of apolipoprotein A and B-100 in various renal diseases. Kidney Int 1993, 43:430-435